Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism

Autism Research

Volumn 6, Issue 6, 2013, Pages 571-583

  Oblak, Adrian ^a   Gibbs, Terrell T ^a   Blatt, Gene J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT transporters; 5 HT1A receptors; 5 HT2A receptors; Autism; Pharmacotherapy; Selective serotonin reuptake inhibitors (SSRI); Serotonin

Indexed keywords

ARIPIPRAZOLE; CITALOPRAM; FLUOXETINE; RISPERIDONE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; AUTISM; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; INNERVATION; LIGAND BINDING; MALE; MODULATION; PRIORITY JOURNAL; RECEPTOR BINDING; YOUNG ADULT;

5-HT TRANSPORTERS; 5-HT1A RECEPTORS; 5-HT2A RECEPTORS; AUTISM; PHARMACOTHERAPY; SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI); SEROTONIN;

ADOLESCENT; ADULT; AUTISTIC DISORDER; AUTOPSY; BRAIN; FEMALE; GYRUS CINGULI; HUMANS; MALE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84890793543     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1317     Document Type: Article

References (68)

1. Abramson, R.K., Wright, H.H., Carpenter, R., Brennan, W., Lumpuy, O., etal. (1989). Elevated blood serotonin in autistic probands and their first-degree relatives. Journal of Autism and Developmental Disorders, 19, 397-407.
2. Adrien, J.L., Barthélémy, C., Perrot, A., Roux, S., Lenoir, P., etal. (1992). Validity and reliability of the infant behavioral summarized evaluation (IBSE): A rating scale for the assessment of young children with autism and developmental disorders. Journal of Autism and Developmental Disorders, 22, 375-394.
3. Anderson, G.M., Freedman, D.X., Cohen, D.J., Volkmar, F.R., Hoder, E.L., etal. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 28, 885-900.
4. Azmitia, E.C., Singh, J.S., & Whitaker-Azmitia, P.M. (2011). Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology, 60, 1347-1354.
5. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., etal. (1998). A clinicopathological study of autism. Brain: A Journal of Neurology, 121(Pt 5), 889-905.
6. Baio, J. (2012). Prevalence of autism spectrum disorders - Autism and developmental disabilities monitoring network, 14 sites, United States, 2008, National Center on Birth Defects and Developmental Disabilities, CDC. Morbidity and Mortality Weekly Report (MMWR), Surveillance Summaries, 61, 1-19.
7. Bauman, M., & Kemper, T.L. (1985). Histoanatomic observations of the brain in early infantile autism. Neurology, 35, 866-874.
8. Blankenship, K., Erickson, C.A., Stigler, K.A., Posey, D.J., & McDougle, C.J. (2010). Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Pediatric Health, 4, 375-381.
9. Brodmann, K. (1909). Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues. Leipzig: Johann Ambrosius Barth Verlag.
10. Brune, C.W., Kim, S., Salt, J., Leventhal, B.L., Lord, C., & Cook, E.H. (2006). 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. The American Journal of Psychiatry, 163, 2148-2156.
11. Casanova, M.F. (2004). White matter volume increase and minicolumns in autism. Annals of Neurology, 56, 453.
12. Casanova, M.F. (2006). Neuropathological and genetic findings in autism: The significance of a putative minicolumnopathy. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 12, 435-441.
13. Casanova, M.F., Buxhoeveden, D., & Gomez, J. (2003). Disruption in the inhibitory architecture of the cell minicolumn: Implications for autism. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 9, 496-507.
14. Chifari, R., Guerrini, R., Pierluigi, M., Cavani, S., Sgrò, V., etal. (2002). Mild generalized epilepsy and developmental disorder associated with large inv dup(15). Epilepsia, 43, 1096-1100.
15. Ching, H., & Pringsheim, T. (2012). Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, (5), CD009043. doi:10.1002/14651858.CD009043.pub2.
16. Cook, E.H., & Leventhal, B.L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348-354.
17. Cook, E.H. Jr, Arora, R.C., Anderson, G.M., Berry-Kravis, E.M., Yan, S.Y., etal. (1993). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sciences, 52, 2005-2015.
18. Couturier, J.L., & Nicolson, R. (2002). A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 12, 243-248.
19. Dalton, K.M., Nacewicz, B.M., Johnstone, T., Schaefer, H.S., Gernsbacher, M.A., etal. (2005). Gaze fixation and the neural circuitry of face processing in autism. Nature Neuroscience, 8, 519-526.
20. Daly, E.M., Deeley, Q., Ecker, C., Craig, M., Hallahan, B., etal. (2012). Serotonin and the neural processing of facial emotions in adults with autism: An fMRI study using acute tryptophan depletion. Archives of General Psychiatry, 69, 1003-1013.
21. DeLong, G.R., Teague, L.A., & McSwain Kamran, M. (1998). Effects of fluoxetine treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology, 40, 551-562.
22. Geary, W.A., Toga, A.W., & Wooten, G.F. (1985). Quantitative film autoradiography for tritium: Methodological considerations. Brain Research, 337, 99-108.
23. Gillberg, C., Ehlers, S., Schaumann, H., Jakobsson, G., Dahlgren, S.O., etal. (1990). Autism under age 3 years: A clinical study of 28 cases referred for autistic symptoms in infancy. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 31, 921-934.
24. Goldberg, J., Anderson, G.M., Zwaigenbaum, L., Hall, G.B., Nahmias, C., etal. (2009). Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39, 97-104.
25. Hadjikhani, N., Joseph, R.M., Snyder, J., Chabris, C.F., Clark, J., etal. (2004). Activation of the fusiform gyrus when individuals with autism spectrum disorder view faces. NeuroImage, 22, 1141-1150.
26. Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., etal. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 30, 582-589.
27. Hoshino, Y., Kaneko, M., Yashima, Y., Kumashiro, H., Volkmar, F.R., & Cohen, D.J. (1987). Clinical features of autistic children with setback course in their infancy. The Japanese Journal of Psychiatry and Neurology, 41, 237-245.
28. Hranilovic, D., Bujas-Petkovic, Z., Vragovic, R., Vuk, T., Hock, K., & Jernej, B. (2007). Hyperserotonemia in adults with autistic disorder. Journal of Autism and Developmental Disorders, 37, 1934-1940.
29. Kanwisher, N., McDermott, J., & Chun, M.M. (1997). The fusiform face area: A module in human extrastriate cortex specialized for face perception. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 17, 4302-4311.
30. King, B.H., Hollander, E., Sikich, L., McCracken, J.T., Scahill, L., etal. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66, 583-590.
31. Lam, K.S.L., Aman, M.G., & Arnold, L.E. (2006). Neurochemical correlates of autistic disorder: A review of the literature. Research in Developmental Disabilities, 27, 254-289.
32. Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., etal. (1999). Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biological Psychiatry, 45, 158-163.
33. Leventhal, B.L., Cook, E.H. Jr, Morford, M., Ravitz, A., & Freedman, D.X. (1990). Relationships of Whole Blood Serotonin and Plasma Norepinephrine Within Families. Journal of Autism and Developmental Disorders, 20(4), 499-511.
34. López-Figueroa, A.L., Norton, C.S., López-Figueroa, M.O., Armellini-Dodel, D., Burke, S., etal. (2004). Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biological Psychiatry, 55, 225-233.
35. Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M.M., & Kuikka, J.T. (2008). Serotonin and dopamine transporter binding in children with autism determined by SPECT. Developmental Medicine and Child Neurology, 50, 593-597.
36. Mandell, D.S., Morales, K.H., Marcus, S.C., Stahmer, A.C., Doshi, J., & Polsky, D.E. (2008). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, 441-448.
37. McBride, P.A., Anderson, G.M., Hertzig, M.E., Snow, M.E., Thompson, S.M., etal. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767-776.
38. McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., etal. (2005). Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry, 162, 1142-1148.
39. Merlet, I., Ryvlin, P., Costes, N., Dufournel, D., Isnard, J., etal. (2004). Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. NeuroImage, 22, 886-896.
40. Meschaks, A., Lindstrom, P., Halldin, C., Farde, L., & Savic, I. (2005). Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Archives of Neurology, 62, 946-950.
41. Murphy, D.G.M., Daly, E., Schmitz, N., Toal, F., Murphy, K., etal. (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: An in vivo SPECT study. The American Journal of Psychiatry, 163, 934-936.
42. Nagaraj, R., Singhi, P., & Malhi, P. (2006). Risperidone in children with autism: Randomized, placebo-controlled, double-blind study. Journal of Child Neurology, 21, 450-455.
43. Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., etal. (2010). Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Archives of General Psychiatry, 67, 59-68.
44. Namerow, L.B., Thomas, P., Bostic, J.Q., Prince, J., & Monuteaux, M.C. (2003). Use of citalopram in pervasive developmental disorders. Journal of Developmental and Behavioral Pediatrics: JDBP, 24, 104-108.
45. Nasr, S., Liu, N., Devaney, K.J., Yue, X., Rajimehr, R., etal. (2011). Scene-selective cortical regions in human and nonhuman primates. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31, 13771-13785.
46. Oblak, A., Gibbs, T.T., & Blatt, G.J. (2009). Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Research, 2, 205-219.
47. Oblak, A., Gibbs, T.T., & Blatt, G.J. (2010). Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in autism. Journal of Neurochemistry, 114, 1414-1423.
48. Oblak, A., Gibbs, T.T., & Blatt, G.J. (2011). Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Research, 1380, 218-228.
49. Oblak, A., Kemper, T.L., Bauman, M.L., & Blatt, G.J. (2011). Altered posterior cingulate cortical cytoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism. Autism Research, 4, 200-211.
50. Oswald, D.P., & Sonenklar, N.A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17, 348-355.
51. Pagani, M., Manouilenko, I., Stone-Elander, S., Odh, R., Salmaso, D., etal. (2012). Brief report: Alterations in cerebral blood flow as assessed by PET/CT in adults with autism spectrum disorder with normal IQ. Journal of Autism and Developmental Disorders, 42, 313-318.
52. Palfi, A., Hatvani, L., & Gulya, K. (1998). A new quantitative film autoradiographic method of quantifying mRNA transcripts for in situ hybridizations. The Journal of Histochemistry and Cytochemistry, 46, 1141-1149.
53. Pandina, G.J., Aman, M.G., & Findling, R.L. (2006). Risperidone in the management of disruptive behavior disorders. Journal of Child and Adolescent Psychopharmacology, 16, 379-392.
54. Piven, J., Tsai, G.C., Nehme, E., Coyle, J.T., Chase, G.A., & Folstein, S.E. (1991). Platelet serotonin, a possible marker for familial autism. Journal of Autism and Developmental Disorders, 21, 51-59.
55. Posey, D.J., Erickson, C.A., Stigler, K.A., & McDougle, C.J. (2006). The use of selective serotonin reuptake inhibitors in autism and related disorders. Journal of Child and Adolescent Psychopharmacology, 16, 181-186.
56. Schain, R.J., & Freedman, D.X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. The Journal of Pediatrics, 58, 315-320.
57. Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., etal. (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114, 634-641.
58. Simms, M.L., Kemper, T.L., Timbie, C.M., Bauman, M.L., & Blatt, G.J. (2009). The anterior cingulate cortex in autism: Heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathologica, 118, 673-684.
59. Singh, V.K., Singh, E.A., & Warren, R.P. (1997). Hyperserotoninemia and Serotonin Receptor Antibodies in Children with Autism but Not Mental Retardation. Biological Psychiatry, 41(6), 753-755. doi:10.1016/S0006-3223(96)00522-7.
60. Surguladze, S.A., Elkin, A., Ecker, C., Kalidindi, S., Corsico, A., etal. (2008). Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces. Genes, Brain, and Behavior, 7, 543-551.
61. Sutcliffe, J.S., Delahanty, R.J., Prasad, H.C., McCauley, J.L., Han, Q., etal. (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. American Journal of Human Genetics, 77, 265-279.
62. Tadori, Y., Miwa, T., Tottori, K., Burris, K.D., Stark, A., etal. (2005). Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. European Journal of Pharmacology, 515, 10-19.
63. Uddin, L.Q., Menon, V., Young, C.B., Ryali, S., Chen, T., etal. (2011). Multivariate searchlight classification of structural magnetic resonance imaging in children and adolescents with autism. Biological Psychiatry, 70, 833-841.
64. van Kooten, I.A., Palmen, S.J., von Cappeln, P., Steinbusch, H.W., Korr, H., etal. (2008). Neurons in the fusiform gyrus are fewer and smaller in autism. Brain, 131, 987-999.
65. Wassink, T.H., Hazlett, H.C., Epping, E.A., Arndt, S., Dager, S.R., etal. (2007). Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Archives of General Psychiatry, 64, 709-717.
66. Weiner, K.S., & Grill-Spector, K. (2010). Sparsely-distributed organization of face and limb activations in human ventral temporal cortex. NeuroImage, 52, 1559-1573.
67. Weng, S.-J., Wiggins, J.E., Peltier, S.J., Carrasco, M., Risi, S., etal. (2010). Alterations of resting state functional connectivity in the default network in adolescents with autism spectrum disorders. Brain Research, 1313, 202-214.
68. West, L., & Waldrop, J. (2006). Risperidone use in the treatment of behavioral symptoms in children with autism. Pediatric Nursing, 32, 545-549.